Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranibizumab for persistent diabetic macular edema after bevacizumab
NCT01845844Phase 2Unknown
- Sponsor
- Southeast Retina Center
- Start
- Apr 2013
- Primary completion
- Jan 2015
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ranibizumab in diabetic macular edema (DME), sponsored by Southeast Retina Center. Status: unknown.
02
Drugs
ranibizumab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT01845844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01845844.